Skip to main content
Erschienen in: The Journal of Obstetrics and Gynecology of India 4/2021

05.03.2021 | Original Article

Clinical and Reproductive Characteristics of Patients with Mixed Gonadal Dysgenesis (45,X/46, XY)

verfasst von: Darvin V. Das, P. K. Jabbar

Erschienen in: The Journal of Obstetrics and Gynecology of India | Ausgabe 4/2021

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Mixed gonadal dysgenesis (MGD) or 45,X/46,XY mosaicism is a sex chromosomal disorder of sexual development. We aim to characterize the clinical and reproductive features of 45X/46 XY attending tertiary care center in Kerala.

Materials and Method

Retrospective review of clinical records which include clinical presentation, hormonal profile, cytogenetics, psychosexual assessment, and histopathology of gonadectomy specimen of ten cases of 45X/46 XY mosaicism who attended Endocrinology/ OBG out patient department from 2008 to 2020.

Results

The mean ages of all the cases were 12 ± 3.79 years (± 2 SD). Short stature was universally seen. Virilisation was the most common manifestation (80%) followed by delayed puberty (20%). Autoimmune thyroid disease was seen in 40% of cases. We noticed a delayed presentation in our clinical study. 45X/46 XY subjects who wished to continue as female underwent gonadectomy and were feminized with hormone replacement therapy. Male 45X/46 XY who retained their undescended testis is planned for periodic surveillance for malignancy.

Conclusion

45X/46 XY may present like Turner’s syndrome in clinical practice. Early counseling and gender assignment by a panel of specialists are crucial. Delayed presentation is less commonly encountered now a day and may pose a clinical challenge. Management in 45X/46 XY is multi-disciplinary which includes Turner’s like surveillance, proper sex assignment, timely genital reconstruction surgeries, gonadectomy, gonadal monitoring, and hormonal replacement therapy is needed.
Literatur
1.
Zurück zum Zitat Pan L, Su Z, Song J, Xu W, Liu X, Zhang L, Li S. Multidisciplinary collaboration team of DSD management at Shenzhen Children’s Hospital. Growth data and tumour risk of 32 Chinese children and adolescents with 45, X/46. XY Mosaicism BMC Pediatr. 2019;19(1):143.CrossRef Pan L, Su Z, Song J, Xu W, Liu X, Zhang L, Li S. Multidisciplinary collaboration team of DSD management at Shenzhen Children’s Hospital. Growth data and tumour risk of 32 Chinese children and adolescents with 45, X/46. XY Mosaicism BMC Pediatr. 2019;19(1):143.CrossRef
2.
Zurück zum Zitat Cools M, Boter M, van Gurp R, Stoop H, Poddighem P, et al. Impact of the Y-containing cell line on histological differentiation patterns in dysgenetic gonads. Clin Endocrinol. 2007;67:184–92.CrossRef Cools M, Boter M, van Gurp R, Stoop H, Poddighem P, et al. Impact of the Y-containing cell line on histological differentiation patterns in dysgenetic gonads. Clin Endocrinol. 2007;67:184–92.CrossRef
3.
Zurück zum Zitat Ahmed SF, Khwaja O, Hughes IA. The role of a clinical score in the assessment of ambiguous genitalia. BJU Int. 2000;85:120–212.CrossRef Ahmed SF, Khwaja O, Hughes IA. The role of a clinical score in the assessment of ambiguous genitalia. BJU Int. 2000;85:120–212.CrossRef
4.
Zurück zum Zitat Farrugia MK, Sebire NJ, Achermann JC, Eisawi A, Duffy PG, Mushtaq I. Clinical and gonadal features and early surgical management of 45, X/46, XY and 45, X/47, XYY chromosomal mosaicism presenting with genital anomalies. J Pediatr Urol. 2013;9(2):139–44.CrossRef Farrugia MK, Sebire NJ, Achermann JC, Eisawi A, Duffy PG, Mushtaq I. Clinical and gonadal features and early surgical management of 45, X/46, XY and 45, X/47, XYY chromosomal mosaicism presenting with genital anomalies. J Pediatr Urol. 2013;9(2):139–44.CrossRef
5.
Zurück zum Zitat Tosson H, Rose SR, Gartner LA. Children with 45, X/46, XY karyotype from birth to adult height. Hom Res Paediatr. 2010;74(3):190–200.CrossRef Tosson H, Rose SR, Gartner LA. Children with 45, X/46, XY karyotype from birth to adult height. Hom Res Paediatr. 2010;74(3):190–200.CrossRef
6.
Zurück zum Zitat Jorgensen KT, Rostgaard K, Bache I, Biggar RJ, Nielsen NM, Tommerup N, Frisch M. Autoimmune diseases in women with Turner’s syndrome. Arthritis Rheumatology. 2010;62:658–66.CrossRef Jorgensen KT, Rostgaard K, Bache I, Biggar RJ, Nielsen NM, Tommerup N, Frisch M. Autoimmune diseases in women with Turner’s syndrome. Arthritis Rheumatology. 2010;62:658–66.CrossRef
7.
Zurück zum Zitat Clinical Practice Guideline Turner syndrome clinical. C H Gravholt and others. Eur J Endocrinol. 2017;177:G1–70.CrossRef Clinical Practice Guideline Turner syndrome clinical. C H Gravholt and others. Eur J Endocrinol. 2017;177:G1–70.CrossRef
8.
Zurück zum Zitat Zhong Q, Layman LC. Genetic considerations in the patient with Turner syndrome–45, X with or without mosaicism. Fertil Steril. 2012;98(4):775–9.CrossRef Zhong Q, Layman LC. Genetic considerations in the patient with Turner syndrome–45, X with or without mosaicism. Fertil Steril. 2012;98(4):775–9.CrossRef
9.
Zurück zum Zitat Harrington J, Palmert MR, Hamilton J. Use of local data to enhance uptake of published recommendations: an example from the diagnostic evaluation of precocious puberty. Arch Dis Child. 2014;99(1):15–20.CrossRef Harrington J, Palmert MR, Hamilton J. Use of local data to enhance uptake of published recommendations: an example from the diagnostic evaluation of precocious puberty. Arch Dis Child. 2014;99(1):15–20.CrossRef
10.
Zurück zum Zitat Cortes D, Thorup JM, Visfeldt J. Cryptorchidism: aspects of fertility and neoplasms. Horm Res. 2001;55:21–7.PubMed Cortes D, Thorup JM, Visfeldt J. Cryptorchidism: aspects of fertility and neoplasms. Horm Res. 2001;55:21–7.PubMed
11.
Zurück zum Zitat Das DV, Jabbar PK, Gomez R, Seena TP. Hemoptysis: a rare presentatuin of mixed gonadal dysgenesis. J Hum Reprod Sci. 2020;13:242–4.CrossRef Das DV, Jabbar PK, Gomez R, Seena TP. Hemoptysis: a rare presentatuin of mixed gonadal dysgenesis. J Hum Reprod Sci. 2020;13:242–4.CrossRef
12.
Zurück zum Zitat Kumar J, Kumar V, Bhatia V, et al. Managing disorder of sexual development surgically: a single center experience. Indian J Urol. 2012;28:286–91.CrossRef Kumar J, Kumar V, Bhatia V, et al. Managing disorder of sexual development surgically: a single center experience. Indian J Urol. 2012;28:286–91.CrossRef
13.
Zurück zum Zitat Hemesath TP, de Paula LCP, Carvalho CG, Leite JCL, Guaragna-Filho G, Costa EC. Controversies on timing of sex assignment and surgery in individuals with disorders of sex development: a perspective. Front Pediatr. 2019;6:419.CrossRef Hemesath TP, de Paula LCP, Carvalho CG, Leite JCL, Guaragna-Filho G, Costa EC. Controversies on timing of sex assignment and surgery in individuals with disorders of sex development: a perspective. Front Pediatr. 2019;6:419.CrossRef
14.
Zurück zum Zitat Cools M, Pleskacova J, Stoop H, et al. On behalf of the mosaicism collaborative group, gonadal pathology and tumor risk in relation to clinical characteristics in patients with 45, X/46 XY Mosaicism. J Clin Endocrinol Metabol. 2011;96:1171–80.CrossRef Cools M, Pleskacova J, Stoop H, et al. On behalf of the mosaicism collaborative group, gonadal pathology and tumor risk in relation to clinical characteristics in patients with 45, X/46 XY Mosaicism. J Clin Endocrinol Metabol. 2011;96:1171–80.CrossRef
Metadaten
Titel
Clinical and Reproductive Characteristics of Patients with Mixed Gonadal Dysgenesis (45,X/46, XY)
verfasst von
Darvin V. Das
P. K. Jabbar
Publikationsdatum
05.03.2021
Verlag
Springer India
Erschienen in
The Journal of Obstetrics and Gynecology of India / Ausgabe 4/2021
Print ISSN: 0971-9202
Elektronische ISSN: 0975-6434
DOI
https://doi.org/10.1007/s13224-021-01448-3

Weitere Artikel der Ausgabe 4/2021

The Journal of Obstetrics and Gynecology of India 4/2021 Zur Ausgabe

Antikörper-Wirkstoff-Konjugat hält solide Tumoren in Schach

16.05.2024 Zielgerichtete Therapie Nachrichten

Trastuzumab deruxtecan scheint auch jenseits von Lungenkrebs gut gegen solide Tumoren mit HER2-Mutationen zu wirken. Dafür sprechen die Daten einer offenen Pan-Tumor-Studie.

Mammakarzinom: Senken Statine das krebsbedingte Sterberisiko?

15.05.2024 Mammakarzinom Nachrichten

Frauen mit lokalem oder metastasiertem Brustkrebs, die Statine einnehmen, haben eine niedrigere krebsspezifische Mortalität als Patientinnen, die dies nicht tun, legen neue Daten aus den USA nahe.

Neue S3-Leitlinie zur unkomplizierten Zystitis: Auf Antibiotika verzichten?

15.05.2024 Harnwegsinfektionen Nachrichten

Welche Antibiotika darf man bei unkomplizierter Zystitis verwenden und wovon sollte man die Finger lassen? Welche pflanzlichen Präparate können helfen? Was taugt der zugelassene Impfstoff? Antworten vom Koordinator der frisch überarbeiteten S3-Leitlinie, Prof. Florian Wagenlehner.

Gestationsdiabetes: In der zweiten Schwangerschaft folgenreicher als in der ersten

13.05.2024 Gestationsdiabetes Nachrichten

Das Risiko, nach einem Gestationsdiabetes einen Typ-2-Diabetes zu entwickeln, hängt nicht nur von der Zahl, sondern auch von der Reihenfolge der betroffenen Schwangerschaften ab.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.